MYP_102417
Basic Information
Leuprolide
Anticancer
Hormonal / Endocrine Hormone peptide
not Standard
9 amino acids
-
contains X representing unresolved or non-standard residue
Sequence
XHWSYLLRP
Physicochemical Analysis
0.00 Da
0.00
0.00
0.00
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0053520 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
GnRH analog
32630
Structure & Mods
linear synthetic GnRH analog [Linear]
mixed L/D amino-acid peptide [Mixed]
Pyroglutamate
Ethylamide
D-Leu at position 6
Bio-Activity Profile
Endocrine GnRH agonist Hormone therapy
approx. 3 h
RECORD: Rec_0335073 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]; synthetic construct [Synthetic]
GnRH
9606;32630
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Pyroglutamate
N-ethylamide
Non-standard residues/X at 1
Bio-Activity Profile
GnRH agonist Endocrine Anticancer
Human GnRH receptor
Clinical/Human: Leuprolide has a terminal elimination half-life of approximately 3 h